Using Syrian mice in the laboratory, the researchers found that one of the drugs, ranitidine bismuth citrate, was a “strong anti-SARS-Cove-2 agent”.
University of Hong Kong researcher, Ranming Wang, told reporters Monday, while the team was presenting the study, that ranitidine bismuth citrate “is able to reduce the viral load in the lung of an infected mouse by tenfold. … Our findings show that this drug is a potential antiviral agent.” In the case of COVID-19. “
The new Corona virus has caused the death of more than a million people since its appearance in China last December, before spreading around the world.
As scientists struggle to find an effective vaccine, they are also looking for readily available drugs that may alleviate symptoms caused by Covid-19 disease or help the body fight infection.
Both remdesivir, a broad-spectrum antiviral drug, and dexamethasone, a type of corticosteroid, were found to have some success against the virus.
Doctors used both drugs to treat US President Donald Trump after contracting Covid-19.
However, remdesivir is expensive and there is a global shortage of stocks. Dexamethasone has immunosuppressive effects that are risky for all but the sickest of all patients.
These were the details of the news Good news from Hong Kong regarding the treatment of Corona for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
